finasteride |
98319-26-7 |
Proscar |
Propecia |
Finastid |
Prostide |
Chibro-Proscar |
MK-906 |
Finpecia |
Finasterida |
Finasteridum |
MK 906 |
UNII-57GNO57U7G |
(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide |
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno5,4-fquinoline-7-carboxamide |
CHEMBL710 |
N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide |
57GNO57U7G |
CHEBI:5062 |
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno5,4-fquinoline-1-carboxamide |
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno5,4-fquinoline-7-carboxamide |
N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-en-17beta-carboxamide |
MFCD00869737 |
Finasteridum INN-Latin |
C23H36N2O2 |
Finasterida INN-Spanish |
DSSTox_CID_625 |
DSSTox_RID_75699 |
DSSTox_GSID_20625 |
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-dimethylethyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno5,4-fquinoline-7-carboxamide |
Andozac |
4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha,17beta)- |
Propecia (TN) |
SMR000466304 |
Proscar (TN) |
MK 0906 |
MK-0906 |
CCRIS 7438 |
HSDB 6793 |
MK906 |
SR-01000759414 |
BRN 4269024 |
L-652,931 |
17beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androst-1-en-3-one |
NCGC00016965-01 |
Finasteride USAN:USP:INN:BAN |
N-(2-Methyl-2-propyl)-3-oxo-4-aza-5-alpha-androst-1-ene-17-beta-carboxamide |
CAS-98319-26-7 |
YM-152 |
KS-1058 |
Finasteride (Proscar) |
Prestwick0_000717 |
Prestwick1_000717 |
Prestwick2_000717 |
Prestwick3_000717 |
N-(2-methyl-2-propyl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide |
SCHEMBL5509 |
BSPBio_000933 |
MLS000759404 |
MLS001165768 |
MLS001424046 |
Finasteride (JAN/USP/INN) |
SPBio_002854 |
BPBio1_001027 |
GTPL6818 |
DTXSID3020625 |
BCPP000229 |
HMS1570O15 |
HMS2051F09 |
HMS2090G22 |
HMS2097O15 |
HMS2235L23 |
HMS3714O15 |
4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno5,4-fquinoline-7-carboxylic acid tert-butylamide |
ACT02599 |
EX-A1951 |
ZINC3782599 |
Tox21_110717 |
Tox21_201506 |
Tox21_302744 |
BDBM50334788 |
NSC741485 |
NSC757443 |
s1197 |
AKOS015894916 |
Tox21_110717_1 |
BCP9000685 |
CCG-100937 |
CS-1767 |
DB01216 |
Finasteride, >=98% (HPLC), powder |
NC00187 |
NSC 741485 |
NSC 759318 |
NSC-741485 |
NSC-757443 |
NCGC00093560-05 |
NCGC00256334-01 |
NCGC00259057-01 |
BF164456 |
CPD000466304 |
HY-13635 |
BCP0726000222 |
AB00513901 |
D00321 |
J10122 |
32329-EP2272827A1 |
32329-EP2275420A1 |
32329-EP2280012A2 |
32329-EP2281815A1 |
32329-EP2292615A1 |
32329-EP2295055A2 |
32329-EP2295416A2 |
32329-EP2295426A1 |
32329-EP2295427A1 |
32329-EP2298748A2 |
32329-EP2298764A1 |
32329-EP2298765A1 |
32329-EP2298768A1 |
32329-EP2301928A1 |
32329-EP2301933A1 |
32329-EP2305640A2 |
32329-EP2305642A2 |
32329-EP2305671A1 |
32329-EP2311453A1 |
32329-EP2311808A1 |
32329-EP2311825A1 |
32329-EP2311827A1 |
32329-EP2311829A1 |
32329-EP2311840A1 |
AB00513901-07 |
AB00513901-08 |
AB00513901_09 |
Finasteride, VETRANAL(TM), analytical standard |
319F267 |
A845840 |
Q424167 |
SR-01000759414-4 |
SR-01000759414-6 |
BRD-K01095011-001-03-5 |
BRD-K01095011-001-15-9 |
Finasteride, British Pharmacopoeia (BP) Reference Standard |
Finasteride, European Pharmacopoeia (EP) Reference Standard |
(1-PHENYL-METH-(E)-YLIDENE-AMINO)-ACETICACIDETHYLESTER |
(17beta-(N-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one |
Finasteride, United States Pharmacopeia (USP) Reference Standard |
(5?,17?)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide |
4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5-alpha,17-beta)- |
4-Azaandrost-1-ene-17-carboxamide,1-dimethylethyl)-3-oxo-, (5.alpha., 17.beta.)- |
Finasteride for peak identification, European Pharmacopoeia (EP) Reference Standard |
(1S,2R,7R,10S,11S,14S,15S)-N-tert-butyl-2,15-dimethyl-5-oxo-6-azatetracyclo8.7.0.0^{2,7}.0^{11,15}heptadec-3-ene-14-carboxamide |
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-isobutyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno5,4-fquinoline-1-carboxamide |
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-isobutyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno5,4-fquinoline-1-carboxamide;Finasteride |
(4AR,4BS,6AS,7S,9AS,9BS,11AR)-4A,6A-DIMETHYL-2-OXO-2,4A,4B,5,6,6A,7,8,9,9A,9B,10,11,11A-TETRADECAHYDRO-1H-INDENO5,4-FQUINOLINE-7-CARBOXYLIC ACID TERT-BUTYLAMIDE |
(4aR,4bS,6aS,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno5,4-fquinoline-7-carboxylic acid tert-butylamide |
(4aR,6aS)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno5,4-fquinoline-7-carboxylic acid tert-butylamide |
(4aR,6aS,11aR)-4a,6a-Dimethyl-2-oxo-hexadecahydro-indeno5,4-fquinoline-7-carboxylic acid tert-butylamide |
(4aR,6aS,7S)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno5,4-fquinoline-7-carboxylic acid tert-butylamide |
(4aR,6aS,7S,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno5,4-fquinoline-7-carboxylic acid tert-butylamide |
(R)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno5,4-fquinoline-7-carboxylic acid tert-butylamide |
140375-21-9 |
4a,6a,9a-Trimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno5,4-fquinoline-7-carboxylic acid (Finasteride) |
4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno5,4-fquinoline-7-carboxylic acid tert-butylamide(Finasteride) |
|